Skip to main content Scroll Top
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
16 March 2026
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE tests light stimulation on neurodegenerative diseases
23 May 2023
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
1 October 2019

Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease

Clinical Trials on Alzheimer’s Disease Asia (CTAD Asia) 2019, Beijing
Read the article

Guillaume Blivet, Laura Auboyer, Johann Meunier, François J. Roman, Jacques Touchon.

Share this article